Skip to main content
SpringerLink
Log in

Increased risk of infections with alemtuzumab?

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Martin SI, Marty FM, Fiumara K, Treon SP, Gribben JG, Baden LR.Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. Clinical Infectious Diseases 43: 16-24, No. 1, 1 Jul 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Increased risk of infections with alemtuzumab?. React. Wkly. 1109, 5 (2006). https://doi.org/10.2165/00128415-200611090-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200611090-00014

Keywords

Search

Navigation